Drug recall D-0524-2021
Product
Steglatro (ertugliflozin) tablets 15 mg 30 Tablets Rx only NDC 0006-5364-03 Manuf. for: Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Whitehouse Station, NJ 08889, USA
Reason for recall
CGMP Deviations: Intermittent exposure to temperature excursion during storage.
Lots and codes
T013566
Recall details
- Recalling firm
- Cardinal Health Inc., Dublin, OH
- Quantity
- 215 bottles
- Distribution
- FL, GA, SC
- Type
- Voluntary: Firm initiated
- Recall initiated
- March 15, 2021
- Terminated
- June 17, 2024
Related products
- Steglatro – drug information
- NDC 0006-5363 Steglatro · Ertugliflozin Pidolate 5 mg/1 · Merck Sharp & Dohme LLC
- NDC 0006-5364 Steglatro · Ertugliflozin Pidolate 15 mg/1 · Merck Sharp & Dohme LLC